Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
19.68B | 18.61B | 14.93B | 18.67B | 19.18B | 16.49B | Gross Profit |
19.32B | 18.55B | 14.87B | 18.60B | 19.07B | 16.37B | EBIT |
4.46B | 3.69B | 379.00M | 3.22B | 3.66B | 1.01B | EBITDA |
3.85B | 4.15B | 1.12B | 4.08B | 5.99B | 1.24B | Net Income Common Stockholders |
3.39B | 2.92B | 778.00M | 2.83B | 4.16B | 792.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
56.11B | 39.99B | 33.97B | 29.68B | 32.96B | 33.75B | Total Assets |
97.12B | 84.08B | 67.60B | 90.89B | 99.39B | 83.23B | Total Debt |
0.00 | 3.14B | 3.01B | 4.16B | 3.83B | 3.57B | Net Debt |
-56.11B | -36.26B | -30.29B | -24.81B | -28.49B | -29.36B | Total Liabilities |
47.63B | 31.55B | 21.52B | 43.75B | 52.99B | 41.01B | Stockholders Equity |
49.49B | 52.52B | 46.09B | 47.13B | 46.40B | 42.22B |
Cash Flow | Free Cash Flow | ||||
0.00 | 6.99B | 10.64B | -1.14B | -3.23B | 11.49B | Operating Cash Flow |
0.00 | 7.56B | 10.99B | -371.00M | -2.74B | 11.80B | Investing Cash Flow |
0.00 | -734.00M | -4.60B | -911.00M | 1.57B | -136.00M | Financing Cash Flow |
0.00 | -1.89B | -1.56B | -2.05B | -1.43B | -1.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
€355.17M | 14.83 | 7.44% | 7.12% | ― | ― | ||
64 Neutral | $12.87B | 9.81 | 7.76% | 16985.65% | 12.28% | -7.83% | |
€194.84M | 13.79 | 5.79% | 5.71% | ― | ― | ||
77 Outperform | ¥38.81B | 2.44 | 1.02% | -23.80% | 29.20% | ||
74 Outperform | ¥49.77B | 7.40 | 6.84% | 6.95% | 21.10% | ||
67 Neutral | ¥39.64B | 12.74 | 7.52% | 5.78% | 26.02% | ||
65 Neutral | ¥32.99B | 13.64 | 6.38% | 11.94% | 117.54% |